Nigel Smith - 17th World ADC San Diego

Your Flagship Event Driving ADC Innovation, Insights & Connections

Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation
Iza-Bren Is Approved in China for Recurrent/Metastatic Nasopharyngeal Carcinoma
Novartis to acquire Myricx Bio for up to $1.5B, adding cancer-fighting ADC payload platform
Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
J&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio

Nigel Smith

Head, Analytical Services Sterling Pharma Solutions

Seminars

Wednesday 14th October 2026

Assessing the Impact of Different Linker Technologies on Platform Analytical Methods Used in ADC Development

12:30 pm

Evaluating analytical methods used in bioconjugate process development to provide key attribute information
Assessing the impact of a number of newer linkers on those analytics to confirm continued method suitability

Nigel Smith - Speaker at 17th World ADC San Diego Summit

View all Speakers

View Event Brochure